Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities

CONCLUSIONS: Our findings suggest that HPV vaccination which is currently recommended for all unvaccinated persons through age 26 years, is likely to be more beneficial than previously thought as nonavalent HPV vaccine was not available during the time these data were collected.PMID:34294478 | DOI:10.1016/j.vaccine.2021.07.026

Source: Vaccine - July 23, 2021 Category: Allergy & Immunology Authors: P Madhivanan K Krupp M Coudray B Colbert D Ruiz-Perez H Cui N Bokulich G Narasimhan K Mathee R L Cook J Schwebke D Roe Source Type: research